Celgene Expands Use of Medidata’s Technology
Celgene has expanded its eight-year technology relationship with Medidata to add the Medidata Clinical Cloud® as its enterprise technology platform.
Medidata announced that Celgene has expanded its eight-year technology relationship with Medidata to add the Medidata Clinical Cloud® as its enterprise technology platform for all clinical trials worldwide. A Medidata Rave customer since 2008, Celgene will now include Medidata Designer® (study and protocol design); Medidata Grants Manager® (site budgeting and planning); Safety Gateway (safety reporting); Medidata CTMS® (clinical trial management); Medidata SQM® (site quality management) and Medidata Patient Cloud ePRO (electronic patient-reported outcomes). Celgene is also leveraging one of Medidata’s clinical analytics offerings, Medidata Insights, which provides advanced metrics, visualizations and industry data and benchmarks.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
June 4th 2025Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s award for almost $600 million to accelerate vaccine development will be terminated.
